Please assess the completion status of the following clinical trial:

Trial Title: Preventing Urinary Tract Infection Post-Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Presenting at the gynecology clinic for a pre-operatory visit~2. Ability to give informed consent~3. Willing to take cranberry capsules for up to 6 weeks~4. 18 of age or older~Exclusion Criteria:~1. Pregnancy~2. History of nephrolithiasis~3. History of allergy to cranberry~4. Patient on anticoagulant medicine to be re-started during the 4-6 weeks after surgery~5. Less than 18 years old

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Cranberry powder capsules (Type: EXPERIMENTAL): TheraCran® cranberry: based upon proanthocyanidin content, the four cranberry capsules are equivalent to two 8-ounce servings of cranberry juice.~Participants were directed to take two capsules by mouth twice each day (once in the morning and once in the evening) starting at time of discharge for 4-6 weeks, or until their return for their post-operative doctor's visit. Participants were instructed to drink an 8 oz glass of water while taking the capsule with or without food.
- Placebo capsules (Type: PLACEBO_COMPARATOR): Placebo: participants were directed to take two capsules by mouth twice each day (once in the morning and once in the evening) starting at time of discharge for 4-6 weeks, or until their return for their post-operative doctor's visit. Participants were instructed to drink an 8 oz glass of water while taking the capsule with or without food.

Based on this trial design, predict the completion outcome and termination type (if applicable).